Joint pain risk in melanoma patients on immunotherapy
Part of Cancer, Skin clinical trials.
This study looks at whether immunotherapy for melanoma causes joint pain or other joint problems. It uses ultrasound to check joints before and during treatment to find these issues early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stage IIB, IIC, III, or IV melanoma.
- You are about to start treatment with immunotherapy (immune checkpoint inhibitors).
- You are 18 years or older.
- You do not have a chronic joint disease like arthritis or gout.
- You have not had immunotherapy before.
- You can give your consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether injecting immune-boosting drugs directly into melanoma tumors, alongside the immunotherapy pembrolizumab, can help people whose cancer has not responded to previous immunotherapy. It aims to shrink tumors and improve treatment outcomes.
This study looks at how people with advanced melanoma (a serious skin cancer) feel during treatment with immunotherapy. It aims to better understand the symptoms they experience, so doctors can help manage them.
This study tests whether low-dose radiation can ease joint pain and swelling caused by immunotherapy cancer treatment. It aims to help people with arthritis-like symptoms in up to three joints get relief without using more strong medications.
This study looks at how common medicines might interact with immunotherapy (a treatment that helps your immune system fight cancer). Participation could help doctors learn how to better manage side effects and dosing for patients on these treatments.
This study looks at whether physical activity can help reduce side effects from immunotherapy in people with melanoma. You may join if you are starting a certain type of immunotherapy for melanoma.
This study is for people whose immunotherapy (a type of cancer treatment) caused joint pain, swelling, or muscle stiffness. Researchers want to talk to you about how these side effects have affected your life, so they can better understand and help others in the future.
Hear when a new Melanoma Stage III trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.